Community & Public Health

Calif.’s revised eligibility rules for new hep C drugs appear to be easing Medicaid patients’ access to the medications, yet the vast majority of Medicaid patients with hep C still aren't getting the costly drugs, state health officials say.

Health Insurance and Costs, Chronic Disease

When extremely expensive new hepatitis C medications arrived on the market more than two years ago, private health insurers limited access to the very sickest. Now, two new analyses say that approach is shortsighted and counterproductive.

Health Insurance and Costs, Chronic Disease